Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

CTT Pharma Will Utilize Patented Technology for Additional Oral Products

CTTH

(TheNewswire)

CTT Pharmaceutical Holdings Inc

Tampa, Florida, United States – The Newswire – November 14, 2022 – CTT Pharmaceutical Holdings, Inc. (OTC:CTTH) can and will utilize our patents for more deliverables including but not limited to gummies and chewing gum. CTT believes we can help companies with their existing products, by incorporating our fast delivery system. CTT Pharma will start engaging companies with existing products immediately and look to partner with them for product research and development.

Ryan Khouri, CEO of CTT Pharma stated, CTT's ability to use our technology in other deliverables will allow us to expand our reach beyond companies looking to manufacture our dissolvable strips. Thus giving CTT the ability to communicate with more companies and work with them to make their current and future products quicker, which would give them an advantage over their competitors. Expanding our patented technology into additional products can also help CTT create partnerships, generate revenue, and unlock shareholder value.

CTT will keep shareholders updated on further developments.

www.cttpharmaceuticals.com

www.linkedin.com/in/ryan-khouri-679a251b7

Ryan Khouri – 813-606-0060

Copyright (c) 2022 TheNewswire - All rights reserved.